Požymis
More active than typical
Klinikinis pavadinimas: Hyperactivity
Hyperactivity is a condition characterized by constant and unusually high levels of activity, even in situations where it is deemed inappropriate.
Santrauka
- Taip pat vadinama
- Hyperactive behavior, Hyperactive behaviour, Hyperkinetic disorder
- Kūno sistema
- Abnormality of the nervous system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to More active than typical, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test232 genų susiję su More active than typical
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia More active than typical. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| AASSaminoadipate-semialdehyde synthase | Visada | 2 ligose |
| AGO1argonaute RISC component 1 | Visada | 1 ligoje |
| AHDC1AT-hook DNA binding motif containing 1 | Visada | 1 ligoje |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Visada | 1 ligoje |
| APC2APC regulator of Wnt signaling pathway 2 | Visada | 1 ligoje |
| AQP4aquaporin 4 | Visada | 1 ligoje |
| ARID1AAT-rich interaction domain 1A | Visada | 2 ligose |
| ARID2AT-rich interaction domain 2 | Visada | 2 ligose |
| BBS2Bardet-Biedl syndrome 2 | Visada | 1 ligoje |
| CC2D1Acoiled-coil and C2 domain containing 1A | Visada | 1 ligoje |
| DPYSdihydropyrimidinase | Visada | 1 ligoje |
| FAM177A1family with sequence similarity 177 member A1 | Visada | 1 ligoje |
| GCSHglycine cleavage system protein H | Visada | 1 ligoje |
| GNB5G protein subunit beta 5 | Visada | 1 ligoje |
| GON4Lgon-4 like | Visada | 1 ligoje |
| IGF1insulin like growth factor 1 | Visada | 2 ligose |
| JKAMPJNK1/MAPK8 associated membrane protein | Visada | 1 ligoje |
| KDM5Clysine demethylase 5C | Visada | 1 ligoje |
| MANBAmannosidase beta | Visada | 1 ligoje |
| MAU2MAU2 sister chromatid cohesion factor | Visada | 1 ligoje |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Visada | 1 ligoje |
| MID2midline 2 | Visada | 1 ligoje |
| MMADHCmetabolism of cobalamin associated D | Visada | 1 ligoje |
| MSL2MSL complex subunit 2 | Visada | 1 ligoje |
| NSD2nuclear receptor binding SET domain protein 2 | Visada | 1 ligoje |
| PDCD6IPprogrammed cell death 6 interacting protein | Visada | 1 ligoje |
| PNKPpolynucleotide kinase 3'-phosphatase | Visada | 2 ligose |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Visada | 1 ligoje |
| SIN3ASIN3 transcription regulator family member A | Visada | 1 ligoje |
| SLC6A19solute carrier family 6 member 19 | Visada | 1 ligoje |
| TSHRthyroid stimulating hormone receptor | Visada | 3 ligose |
| TTI2TELO2 interacting protein 2 | Visada | 2 ligose |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Visada | 1 ligoje |
| UNC13Aunc-13 homolog A | Visada | 2 ligose |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Labai dažnai (80–99%) | 1 ligoje |
| CUL4Bcullin 4B | Labai dažnai (80–99%) | 2 ligose |
| MECP2methyl-CpG binding protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| PTCH1patched 1 | Labai dažnai (80–99%) | 1 ligoje |
| AFF2ALF transcription elongation factor 2 | Dažnai (30–79%) | 2 ligose |
| ANK3ankyrin 3 | Dažnai (30–79%) | 2 ligose |
Rodyti dar 192 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| AP1G1adaptor related protein complex 1 subunit gamma 1 | Dažnai (30–79%) | 1 ligoje |
| AP2M1adaptor related protein complex 2 subunit mu 1 | Dažnai (30–79%) | 1 ligoje |
| ASH1LASH1 like histone lysine methyltransferase | Dažnai (30–79%) | 1 ligoje |
| ASPMassembly factor for spindle microtubules | Dažnai (30–79%) | 1 ligoje |
| ATP1A1ATPase Na+/K+ transporting subunit alpha 1 | Dažnai (30–79%) | 1 ligoje |
| ATP6V0A1ATPase H+ transporting V0 subunit a1 | Dažnai (30–79%) | 1 ligoje |
| ATP9AATPase phospholipid transporting 9A | Dažnai (30–79%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Dažnai (30–79%) | 1 ligoje |
| CHD2chromodomain helicase DNA binding protein 2 | Dažnai (30–79%) | 2 ligose |
| CUL3cullin 3 | Dažnai (30–79%) | 1 ligoje |
| CUX2cut like homeobox 2 | Dažnai (30–79%) | 1 ligoje |
| DDX3XDEAD-box helicase 3 X-linked | Dažnai (30–79%) | 2 ligose |
| DENND5ADENN domain containing 5A | Dažnai (30–79%) | 1 ligoje |
| DNM1dynamin 1 | Dažnai (30–79%) | 1 ligoje |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Dažnai (30–79%) | 1 ligoje |
| EP300EP300 lysine acetyltransferase | Dažnai (30–79%) | 3 ligose |
| FBXO11F-box protein 11 | Dažnai (30–79%) | 1 ligoje |
| FMR1fragile X messenger ribonucleoprotein 1 | Dažnai (30–79%) | 1 ligoje |
| FRMPD4FERM and PDZ domain containing 4 | Dažnai (30–79%) | 1 ligoje |
| FZR1fizzy and cell division cycle 20 related 1 | Dažnai (30–79%) | 1 ligoje |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Dažnai (30–79%) | 2 ligose |
| GATAD2BGATA zinc finger domain containing 2B | Dažnai (30–79%) | 2 ligose |
| GLRA2glycine receptor alpha 2 | Dažnai (30–79%) | 1 ligoje |
| GNSglucosamine (N-acetyl)-6-sulfatase | Dažnai (30–79%) | 1 ligoje |
| HIVEP2HIVEP zinc finger 2 | Dažnai (30–79%) | 1 ligoje |
| HTThuntingtin | Dažnai (30–79%) | 1 ligoje |
| IFNGinterferon gamma | Dažnai (30–79%) | 1 ligoje |
| INPP5Einositol polyphosphate-5-phosphatase E | Dažnai (30–79%) | 2 ligose |
| KCNK9potassium two pore domain channel subfamily K member 9 | Dažnai (30–79%) | 1 ligoje |
| KLHL20kelch like family member 20 | Dažnai (30–79%) | 1 ligoje |
| KMT2Alysine methyltransferase 2A | Dažnai (30–79%) | 2 ligose |
| LNPKlunapark, ER junction formation factor | Dažnai (30–79%) | 1 ligoje |
| MAPK10mitogen-activated protein kinase 10 | Dažnai (30–79%) | 1 ligoje |
| MBD5methyl-CpG binding domain protein 5 | Dažnai (30–79%) | 1 ligoje |
| NAV3neuron navigator 3 | Dažnai (30–79%) | 1 ligoje |
| NEXMIFneurite extension and migration factor | Dažnai (30–79%) | 2 ligose |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Dažnai (30–79%) | 2 ligose |
| NTNG2netrin G2 | Dažnai (30–79%) | 1 ligoje |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Dažnai (30–79%) | 2 ligose |
| OCA2OCA2 melanosomal transmembrane protein | Dažnai (30–79%) | 1 ligoje |
| POGZpogo transposable element derived with ZNF domain | Dažnai (30–79%) | 2 ligose |
| PUS7pseudouridine synthase 7 | Dažnai (30–79%) | 1 ligoje |
| RAI1retinoic acid induced 1 | Dažnai (30–79%) | 2 ligose |
| RNU2-2RNA, U2 small nuclear 2 | Dažnai (30–79%) | 1 ligoje |
| RNU5B-1RNA, U5B small nuclear 1 | Dažnai (30–79%) | 1 ligoje |
| RUSC2RUN and SH3 domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Dažnai (30–79%) | 2 ligose |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Dažnai (30–79%) | 1 ligoje |
| SHROOM4shroom family member 4 | Dažnai (30–79%) | 1 ligoje |
| SLC2A1solute carrier family 2 member 1 | Dažnai (30–79%) | 1 ligoje |
| SLC6A1solute carrier family 6 member 1 | Dažnai (30–79%) | 1 ligoje |
| SLC6A8solute carrier family 6 member 8 | Dažnai (30–79%) | 1 ligoje |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Dažnai (30–79%) | 2 ligose |
| STAG2STAG2 cohesin complex component | Dažnai (30–79%) | 1 ligoje |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Dažnai (30–79%) | 1 ligoje |
| THRBthyroid hormone receptor beta | Dažnai (30–79%) | 1 ligoje |
| TRAPPC9trafficking protein particle complex subunit 9 | Dažnai (30–79%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Dažnai (30–79%) | 1 ligoje |
| UBE3Aubiquitin protein ligase E3A | Dažnai (30–79%) | 3 ligose |
| UBE3Cubiquitin protein ligase E3C | Dažnai (30–79%) | 1 ligoje |
| WBP4WW domain binding protein 4 | Dažnai (30–79%) | 1 ligoje |
| YWHAZtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | Dažnai (30–79%) | 1 ligoje |
| ZSWIM6zinc finger SWIM-type containing 6 | Dažnai (30–79%) | 1 ligoje |
| ABCD1ATP binding cassette subfamily D member 1 | Kartais (5–29%) | 1 ligoje |
| ADAT3adenosine deaminase tRNA specific 3 | Kartais (5–29%) | 2 ligose |
| ARID1BAT-rich interaction domain 1B | Kartais (5–29%) | 1 ligoje |
| ARPC4actin related protein 2/3 complex subunit 4 | Kartais (5–29%) | 1 ligoje |
| ARXaristaless related homeobox | Kartais (5–29%) | 1 ligoje |
| ATP10AATPase phospholipid transporting 10A (putative) | Kartais (5–29%) | 1 ligoje |
| AUTS2activator of transcription and developmental regulator AUTS2 | Kartais (5–29%) | 2 ligose |
| BAIAP2BAR/IMD domain containing adaptor protein 2 | Kartais (5–29%) | 1 ligoje |
| BCAP31B cell receptor associated protein 31 | Kartais (5–29%) | 1 ligoje |
| BCKDKbranched chain keto acid dehydrogenase kinase | Kartais (5–29%) | 1 ligoje |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Kartais (5–29%) | 2 ligose |
| CACNA1Ecalcium voltage-gated channel subunit alpha1 E | Kartais (5–29%) | 1 ligoje |
| CASKcalcium/calmodulin dependent serine protein kinase | Kartais (5–29%) | 1 ligoje |
| CDK10cyclin dependent kinase 10 | Kartais (5–29%) | 1 ligoje |
| CDKL5cyclin dependent kinase like 5 | Kartais (5–29%) | 1 ligoje |
| CHKAcholine kinase alpha | Kartais (5–29%) | 1 ligoje |
| CICcapicua transcriptional repressor | Kartais (5–29%) | 1 ligoje |
| CLCN3Cl-/H+ antiporter 3 | Kartais (5–29%) | 1 ligoje |
| CLCN4Cl-/H+ antiporter 4 | Kartais (5–29%) | 1 ligoje |
| CNTNAP2contactin associated protein 2 | Kartais (5–29%) | 2 ligose |
| CREBBPCREB binding lysine acetyltransferase | Kartais (5–29%) | 3 ligose |
| DMPKDM1 protein kinase | Kartais (5–29%) | 1 ligoje |
| DMXL2Dmx like 2 | Kartais (5–29%) | 1 ligoje |
| DPF2double PHD fingers 2 | Kartais (5–29%) | 2 ligose |
| DPP6dipeptidyl peptidase like 6 | Kartais (5–29%) | 1 ligoje |
| DYMdymeclin | Kartais (5–29%) | 1 ligoje |
| EBPEBP cholestenol delta-isomerase | Kartais (5–29%) | 2 ligose |
| FOXP2forkhead box P2 | Kartais (5–29%) | 1 ligoje |
| GAMTguanidinoacetate N-methyltransferase | Kartais (5–29%) | 1 ligoje |
| GNAO1G protein subunit alpha o1 | Kartais (5–29%) | 1 ligoje |
| GRIA1glutamate ionotropic receptor AMPA type subunit 1 | Kartais (5–29%) | 1 ligoje |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Kartais (5–29%) | 1 ligoje |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Kartais (5–29%) | 1 ligoje |
| GRM7glutamate metabotropic receptor 7 | Kartais (5–29%) | 1 ligoje |
| HUWE1HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | Kartais (5–29%) | 1 ligoje |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Kartais (5–29%) | 1 ligoje |
| KCNC2potassium voltage-gated channel subfamily C member 2 | Kartais (5–29%) | 1 ligoje |
| KDM6Blysine demethylase 6B | Kartais (5–29%) | 1 ligoje |
| KIF15kinesin family member 15 | Kartais (5–29%) | 1 ligoje |
| LGI1leucine rich glioma inactivated 1 | Kartais (5–29%) | 1 ligoje |
| MED13Lmediator complex subunit 13L | Kartais (5–29%) | 1 ligoje |
| MICU1mitochondrial calcium uptake 1 | Kartais (5–29%) | 1 ligoje |
| MTORmechanistic target of rapamycin kinase | Kartais (5–29%) | 1 ligoje |
| NEUROD2neuronal differentiation 2 | Kartais (5–29%) | 1 ligoje |
| NFIXnuclear factor I X | Kartais (5–29%) | 1 ligoje |
| PAHphenylalanine hydroxylase | Kartais (5–29%) | 2 ligose |
| PAK3p21 (RAC1) activated kinase 3 | Kartais (5–29%) | 1 ligoje |
| PANK2pantothenate kinase 2 | Kartais (5–29%) | 1 ligoje |
| PCDH19protocadherin 19 | Kartais (5–29%) | 1 ligoje |
| PIDD1p53-induced death domain protein 1 | Kartais (5–29%) | 1 ligoje |
| PIGPphosphatidylinositol glycan anchor biosynthesis class P | Kartais (5–29%) | 1 ligoje |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Kartais (5–29%) | 1 ligoje |
| PLA2G6phospholipase A2 group VI | Kartais (5–29%) | 2 ligose |
| PNPpurine nucleoside phosphorylase | Kartais (5–29%) | 1 ligoje |
| PPP2R1Aprotein phosphatase 2 scaffold subunit Aalpha | Kartais (5–29%) | 1 ligoje |
| PUF60poly(U) binding splicing factor 60 | Kartais (5–29%) | 1 ligoje |
| RAC1Rac family small GTPase 1 | Kartais (5–29%) | 1 ligoje |
| RHOBTB2Rho related BTB domain containing 2 | Kartais (5–29%) | 1 ligoje |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Kartais (5–29%) | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Kartais (5–29%) | 1 ligoje |
| SETBP1SET binding protein 1 | Kartais (5–29%) | 1 ligoje |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Kartais (5–29%) | 1 ligoje |
| SIK1salt inducible kinase 1 | Kartais (5–29%) | 1 ligoje |
| SLC1A4solute carrier family 1 member 4 | Kartais (5–29%) | 2 ligose |
| SLC25A13solute carrier family 25 member 13 | Kartais (5–29%) | 1 ligoje |
| SLC25A22solute carrier family 25 member 22 | Kartais (5–29%) | 1 ligoje |
| SLC32A1solute carrier family 32 member 1 | Kartais (5–29%) | 1 ligoje |
| SLC4A10solute carrier family 4 member 10 | Kartais (5–29%) | 1 ligoje |
| SLITRK2SLIT and NTRK like family member 2 | Kartais (5–29%) | 1 ligoje |
| SMAD4SMAD family member 4 | Kartais (5–29%) | 1 ligoje |
| SMARCA4SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | Kartais (5–29%) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Kartais (5–29%) | 1 ligoje |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Kartais (5–29%) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Kartais (5–29%) | 1 ligoje |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Kartais (5–29%) | 1 ligoje |
| SOX11SRY-box transcription factor 11 | Kartais (5–29%) | 1 ligoje |
| SOX4SRY-box transcription factor 4 | Kartais (5–29%) | 1 ligoje |
| SPRED1sprouty related EVH1 domain containing 1 | Kartais (5–29%) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Kartais (5–29%) | 1 ligoje |
| STEEP1STING1 ER exit protein 1 | Kartais (5–29%) | 1 ligoje |
| STXBP1syntaxin binding protein 1 | Kartais (5–29%) | 1 ligoje |
| TMEM147transmembrane protein 147 | Kartais (5–29%) | 1 ligoje |
| TMEM222transmembrane protein 222 | Kartais (5–29%) | 1 ligoje |
| TRIM8tripartite motif containing 8 | Kartais (5–29%) | 1 ligoje |
| TRIP12thyroid hormone receptor interactor 12 | Kartais (5–29%) | 1 ligoje |
| TTI1TELO2 interacting protein 1 | Kartais (5–29%) | 1 ligoje |
| UBTFupstream binding transcription factor | Kartais (5–29%) | 1 ligoje |
| VPS13Avacuolar protein sorting 13 homolog A | Kartais (5–29%) | 1 ligoje |
| WDR62WD repeat domain 62 | Kartais (5–29%) | 1 ligoje |
| YME1L1YME1 like 1 ATPase | Kartais (5–29%) | 1 ligoje |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Retai (1–4 %) | 1 ligoje |
| H3-3AH3.3 histone A | Retai (1–4 %) | 1 ligoje |
| HALhistidine ammonia-lyase | Retai (1–4 %) | 1 ligoje |
| NKX2-1NK2 homeobox 1 | Retai (1–4 %) | 1 ligoje |
| ACY1aminoacylase 1 | Neužfiksuota | 1 ligoje |
| ADNPactivity dependent neuroprotector homeobox | Neužfiksuota | 1 ligoje |
| ADSLadenylosuccinate lyase | Neužfiksuota | 1 ligoje |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Neužfiksuota | 1 ligoje |
| ARG1arginase 1 | Neužfiksuota | 1 ligoje |
| ATRATR checkpoint kinase | Neužfiksuota | 1 ligoje |
| ATRXATRX chromatin remodeler | Neužfiksuota | 1 ligoje |
| CAMTA1calmodulin binding transcription activator 1 | Neužfiksuota | 1 ligoje |
| CCBE1collagen and calcium binding EGF domains 1 | Neužfiksuota | 1 ligoje |
| DHCR77-dehydrocholesterol reductase | Neužfiksuota | 1 ligoje |
| DPYDdihydropyrimidine dehydrogenase | Neužfiksuota | 1 ligoje |
| DRD4dopamine receptor D4 | Neužfiksuota | 1 ligoje |
| DRD5dopamine receptor D5 | Neužfiksuota | 1 ligoje |
| FLCNfolliculin | Neužfiksuota | 1 ligoje |
| GLDCglycine decarboxylase | Neužfiksuota | 1 ligoje |
| HDAC4histone deacetylase 4 | Neužfiksuota | 1 ligoje |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Neužfiksuota | 1 ligoje |
| HGSNATheparan-alpha-glucosaminide N-acetyltransferase | Neužfiksuota | 1 ligoje |
| IL1RAPL1interleukin 1 receptor accessory protein like 1 | Neužfiksuota | 1 ligoje |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Neužfiksuota | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Neužfiksuota | 1 ligoje |
| MED12mediator complex subunit 12 | Neužfiksuota | 1 ligoje |
| NAGLUN-acetyl-alpha-glucosaminidase | Neužfiksuota | 1 ligoje |
| NBNnibrin | Neužfiksuota | 1 ligoje |
| OPHN1oligophrenin 1 | Neužfiksuota | 1 ligoje |
| PDE4Dphosphodiesterase 4D | Neužfiksuota | 1 ligoje |
| PRODHproline dehydrogenase 1 | Neužfiksuota | 1 ligoje |
| RAB39BRAB39B, member RAS oncogene family | Neužfiksuota | 1 ligoje |
| SATB2SATB homeobox 2 | Neužfiksuota | 1 ligoje |
| SGSHN-sulfoglucosamine sulfohydrolase | Neužfiksuota | 1 ligoje |
| SPRsepiapterin reductase | Neužfiksuota | 1 ligoje |
| TAF6TATA-box binding protein associated factor 6 | Neužfiksuota | 1 ligoje |
| TCF20transcription factor 20 | Neužfiksuota | 1 ligoje |
| UQCC2ubiquinol-cytochrome c reductase complex assembly factor 2 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites